A Physician-Completed Digital Tool for Evaluating Disease Progression (Multiple Sclerosis Progression Discussion Tool): Validation Study.

Tjalf Ziemssen Daniela Piani-Meier Bryan Bennett Chloe Johnson Katie Tinsley Andrew Trigg Thomas Hach Frank Dahlke Davorka Tomic Chloe Tolley Mark S Freedman

Published in: Journal of medical Internet research (2020)

The MSProDiscuss tool differentiated RRMS patients from SPMS patients with high sensitivity and specificity. In clinical practice, it may be a useful tool to evaluate early, subtle signs of MS disease progression indicating the evolution of RRMS to SPMS. MSProDiscuss will help assess the current level of progression in an individual patient and facilitate a more informed physician-patient discussion.

Keyphrases

multiple sclerosis
end stage renal disease
primary care
clinical practice
emergency department
case report
ejection fraction
newly diagnosed
chronic kidney disease
mass spectrometry
peritoneal dialysis
prognostic factors
white matter